Tme Pharma Is A Clinical Stage Biotechnology Company Based In Berlingermanydedicated To Developing Innovative Therapies For Aggressive Cancersthe Company Focuses On The Tumor Microenvironment To Enhance The Immune System S Ability To Combat Cancertheir Primary Productnox A12Is Currently Undergoing Clinical Trials For Glioblastoma And Pancreatic Cancershowing Promising Results In Combination With Other Treatments Tme Pharma Is Conducting Phase 1 2 Trials For Nox A12 Combined With Radiotherapy And Anti Vegf For Glioblastomawhich Has Received Fast Track Designation From The Fdafor Pancreatic Cancerthe Company Has Completed Phase 1 2 Trials With Immunotherapy And Has Received Approval For Phase 2 Protocolstme Pharma Is Listed On Euronext Growth Paris Under The Ticker Altme And Is Actively Pursuing Strategic Transactions To Support Its Mission Of Improving Cancer Treatment Outcomes
No conferences found for this company.
| Company Name | Noxxon Pharma Ag |
| Country |
Germany
|
| Address | Max Dohrn Strasse 8 10 10589 Berlin Germany |
| Telephone | Login to View |
| Login to View |
